| | Patients | Controls | pa |
---|
|
---|
Leukocytes | 8.02±1.51 | 6.79±3.39 | 0.108 |
Lymphocytes | % | 23.53±14.06 | 29.97±15.08 | 0.026* |
| Absolute | 1.70±1.59 | 2.06±0.03 | 0.512 |
CD45 | % | 99.79±0.11 | 99.71±0.11 | 0.165 |
CD3 | % | 71.20±3.57 | 75.11±1.79 | 0.398 |
| Absolute | 1.35±1.20 | 1.60±0.07 | 0.478 |
CD4 | % | 48.59±4.09 | 47.76±8.78 | 0.289 |
| Absolute | 0.85±0.94 | 0.99±0.12 | 0.620 |
CD8 | % | 25.10±0.04 | 28.38±1.19 | 0.277 |
| Absolute | 0.48±0.29 | 0.51±0.03 | 0.301 |
CD19 | % | 8.89±11.57 | 10.44±2.07 | 0.478 |
| Absolute | 0.20±0.02 | 0.17±0.03 | 0.512 |
NK | % | 6.73±8.39 | 6.71±5.40 | 0.883 |
| Absolute | 0.14±0.35 | 0.14±0.09 | 0.947 |
Ratio | T/B | 8.54±4.11 | 7.31±2.3 | 0.383 |
| CD4/CD8 | 1.93±0.23 | 1.73±0.33 | 0.157 |